BNB Plus Secures $4.15M in Convertible Preferred Stock Financing Amid Delisting Threat
BNBX is trading near its 52-week low of $0.37 (0.3% above the low) on light trading volume (0.3× avg).
Summary
BNB Plus Corp. has secured initial commitments for $4.15 million in convertible preferred stock financing, with new Series B-1 Preferred Stock priced at a significant premium to the current market price, providing critical capital for a strategic review and digital asset treasury.
Key Events · Financing and Capital Events · BNBX
-
Secures $4.15 Million in Financing
BNB Plus Corp. has secured initial commitments for $4.15 million in convertible preferred stock financing, with a target to raise up to $5 million. This is a substantial capital raise relative to the company's $2.88 million market capitalization.
-
New Preferred Stock Issued at Premium
New Series B-1 Preferred Stock is priced at $1.05 per share, representing a significant premium over the current common stock price of $0.3711. This preferred stock carries an 8% annual dividend and a 1.5x liquidation preference.
-
Existing Investor Exchange
Existing investors will exercise Series E Warrants for approximately $1.65 million in cash and exchange existing common stock and pre-funded warrants for Series B-2 Preferred Stock, priced at $0.38 per share, with a 6% annual dividend and 1.0x liquidation preference.
-
Subsidiary Guarantee and Strategic Review
The obligations of the convertible preferred stock are guaranteed by the company's Digital Asset Treasury (DAT) subsidiaries. Proceeds will fund a comprehensive strategic review of biotechnology assets and digital asset opportunities, led by GlobalStake Infrastructure, LLC.
Analysis · BNBX · Industrial Applications And Services
This financing is a crucial lifeline for BNB Plus Corp., which is facing imminent Nasdaq delisting and significant operating losses. The company is raising $4.15 million through a complex offering of convertible preferred stock and warrants. New Series B-1 Preferred Stock is priced at $1.05 per share, a substantial premium to the current stock price of $0.3711, indicating a notable vote of confidence from institutional investors despite the company's distressed state. The capital will fund a strategic review of its biotechnology assets and digital asset treasury, and the obligations are guaranteed by its digital asset subsidiaries. While the terms are costly (high dividends, liquidation preferences), this capital infusion is essential for the company's near-term survival and its ability to pursue a new strategic direction.
How filings like this one have moved
In the 30 days to Aug 25, 2026, 43.9% of the 999 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BNBX was trading at $0.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9M. The 52-week trading range was $0.37 to $8.70. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.